Limin Tian

886 citations
29 papers · 614 indexed · h-index 13
Topics
Thyroid Disorders and Treatments (16 papers)Growth Hormone and Insulin-like Growth Factors (6 papers)Thyroid Cancer Diagnosis and Treatment (6 papers)

In The Last Decade

Limin Tian

26 papers receiving 604 citations

Peers

Limin Tian
Comparison fields: 5 of 74
  • Endocrinology, Diabetes and Metabolism 391
  • Molecular Biology 145
  • Surgery 105
  • Epidemiology 70
  • Cardiology and Cardiovascular Medicine 60
Replace Myung Hi Yoo with:
Myung Hi Yoo South Korea
Ye An Kim South Korea
Martina Gosteli Switzerland
Nicoleta Cristina Olarescu Norway
Eun‐Gyoung Hong South Korea
Constantinos Panoulis Greece
James A. Kuzman United States
Marcel Fourcaudot United States
Maria Nocera Italy
Parvin Amiri Iran
Limin Tian relative to Myung Hi Yoo South Korea Myung Hi Yoo's profile →
Citations per field
00.5×1.5×2.3×
Myung Hi Yoo · 1×
Citations per year

Countries citing papers authored by Limin Tian

Since Specialization
Citations

This map shows the geographic impact of Limin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Tian more than expected).

Fields of papers citing papers by Limin Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Tian. The network helps show where Limin Tian may publish in the future.

Co-authorship network of co-authors of Limin Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Limin Tian. A scholar is included among the top collaborators of Limin Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limin Tian. Limin Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 5
5 23
6 0
7 10
8 4
9 27
10 23
11 12
12 27
13 4
14 38
15 15
16 50
17 26
18 29
19 14
20 90

About Limin Tian

Limin Tian is a scholar working on Medical Terminology, Endocrinology, Diabetes and Metabolism and Orthopedics and Sports Medicine, having authored 29 papers that have together received 614 indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (16 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Thyroid Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (391 citations), Endocrine and Autonomic Systems (31 citations) and Cancer Research (52 citations). Limin Tian has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Cuixia Gao, Ling Gao, Jiajun Zhao, Laicheng Wang, Liang Yao, Yuan Fang, Kehu Yang, Jing Ni, Hongyan Ma and Jun Guo. Their work appears in journals such as PLoS ONE, Hepatology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026